艾锐威特生物制药 AVBP
$13.64 +$1.41 (+11.53%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.52 -0.85%
开盘$12.40
昨收$12.23
当日区间$12.00 – $13.88
成交量1.40M
市值$672.56M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$52.69M-56.7% YoY
净利润-$49.89M-58.9% YoY
摊薄每股收益-$1.05-16.7% YoY
自由现金流-$39.58M-51.5% YoY
经营现金流-$39.58M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-53.1%
资产收益率-49.3%
投入资本回报率-57.0%
流动比率14.16
负债/资产比率7.1%
现金及投资$373.12M
总负债$33,000.00
净现金（净负债）$373.09M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $52.69M | $46.11M | $177.53M | $38.82M | $38.32M |
| 销售及管理费用 | $10.35M | $8.49M | $24.18M | $6.65M | $6.15M |
| -管理费用 | $10.35M | $8.49M | $24.18M | $6.65M | $6.15M |
| 研发费用 | $42.34M | $37.62M | $153.35M | $32.18M | $32.17M |
| 营业利润 | -$52.69M | -$46.11M | -$177.53M | -$38.82M | -$38.32M |
| 非经营性利息净收入（支出） | $2.80M | $2.79M | $11.23M | $3.28M | $3.34M |
| 非经营性利息收入 | $2.80M | $2.79M | $11.23M | $3.28M | $3.34M |
| 税前利润 | -$49.89M | -$43.32M | -$166.31M | -$35.54M | -$34.98M |
| 净利润 | -$49.89M | -$43.32M | -$166.31M | -$35.54M | -$34.98M |
| 持续经营利润 | -$49.89M | -$43.32M | -$166.31M | -$35.54M | -$34.98M |
| 归属母公司净利润 | -$49.89M | -$43.32M | -$166.31M | -$35.54M | -$34.98M |
| 归属普通股股东净利润 | -$49.89M | -$43.32M | -$166.31M | -$35.54M | -$34.98M |
| 基本每股收益 | -$1.05 | -$0.96 | -$4.32 | -$0.78 | -$0.83 |
| 摊薄每股收益 | -$1.05 | -$0.96 | -$4.32 | -$0.78 | -$0.83 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $394.72M | $349.30M | $333.17M | $333.17M | $326.56M |
| 流动资产合计 | $394.17M | $348.70M | $332.90M | $332.90M | $321.22M |
| 现金及现金等价物与短期投资 | $373.12M | $326.38M | $312.82M | $312.82M | $300.27M |
| -现金及现金等价物 | $154.68M | $62.10M | $45.54M | $45.54M | $112.67M |
| -短期投资 | $218.44M | $264.28M | $267.28M | $267.28M | $187.59M |
| 预付资产 | $1.15M | $1.43M | $186,000.00 | $186,000.00 | $552,000.00 |
| 其他流动资产 | $19.91M | $20.89M | $19.83M | $19.83M | $19.90M |
| 非流动资产合计 | $545,000.00 | $595,000.00 | $272,000.00 | $272,000.00 | $5.34M |
| 固定资产净值 | $370,000.00 | $370,000.00 | $13,000.00 | $13,000.00 | $49,000.00 |
| -固定资产原值 | $370,000.00 | $370,000.00 | $13,000.00 | $13,000.00 | $49,000.00 |
| 一年以上递延资产 | $41,000.00 | $69,000.00 | $69,000.00 | $69,000.00 | – |
| 其他非流动资产 | $134,000.00 | $156,000.00 | $190,000.00 | $190,000.00 | $180,000.00 |
| 负债合计 | $27.88M | $25.32M | $25.95M | $25.95M | $21.56M |
| 流动负债合计 | $27.84M | $25.00M | $25.95M | $25.95M | $21.56M |
| 应付款 | $2.22M | $8.73M | $5.93M | $5.93M | $5.93M |
| -应付账款 | $2.22M | $8.73M | $5.93M | $5.93M | $5.93M |
| 一年内应计费用 | $21.64M | $14.24M | $13.45M | $13.45M | $11.18M |
| 短期债务及融资租赁负债 | $318,000.00 | $99,000.00 | $14,000.00 | $14,000.00 | $56,000.00 |
| -一年内到期融资租赁负债 | $318,000.00 | $99,000.00 | $14,000.00 | $14,000.00 | $56,000.00 |
| 非流动负债合计 | $33,000.00 | $320,000.00 | $0.00 | $0.00 | $0.00 |
| 长期债务及融资租赁负债 | $33,000.00 | $320,000.00 | $0.00 | $0.00 | $0.00 |
| -长期融资租赁负债 | $33,000.00 | $320,000.00 | $0.00 | $0.00 | $0.00 |
| 股东权益合计 | $366.84M | $323.98M | $307.22M | $307.22M | $305.00M |
| 股东权益 | $366.84M | $323.98M | $307.22M | $307.22M | $305.00M |
| 股本 | $5,000.00 | $5,000.00 | $4,000.00 | $4,000.00 | $4,000.00 |
| -普通股 | $5,000.00 | $5,000.00 | $4,000.00 | $4,000.00 | $4,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $864.96M | $772.21M | $711.85M | $711.85M | $673.88M |
| 留存收益 | -$497.85M | -$447.96M | -$404.64M | -$404.64M | -$369.10M |
| 不影响留存收益的损益 | -$267,000.00 | -$270,000.00 | $14,000.00 | $14,000.00 | $206,000.00 |
| 应收款 | – | – | $60,000.00 | $60,000.00 | $505,000.00 |
| -应收税款 | – | – | $0.00 | $0.00 | $505,000.00 |
| -其他应收款 | – | – | $60,000.00 | $60,000.00 | – |
| 投资及预付款 | – | – | $0.00 | $0.00 | $5.11M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$39.58M | -$41.89M | -$160.59M | -$30.66M | -$35.80M |
| 持续经营经营活动现金流净额 | -$39.58M | -$41.89M | -$160.59M | -$30.66M | -$35.80M |
| 持续经营净利润 | -$49.89M | -$43.32M | -$166.31M | -$35.54M | -$34.98M |
| 其他非现金项目 | -$515,000.00 | -$559,000.00 | -$3.03M | – | – |
| 营运资金变动 | $4.16M | -$3.50M | -$3.77M | $4.69M | -$4.54M |
| -预付资产变动 | $1.55M | -$2.56M | -$12.56M | $275,000.00 | -$6.49M |
| -应付账款及应计费用变动 | $2.63M | -$1.02M | $8.81M | $4.42M | $1.96M |
| -其他流动资产变动 | $47,000.00 | $37,000.00 | $0.00 | $0.00 | $0.00 |
| -其他流动负债变动 | -$67,000.00 | $47,000.00 | -$21,000.00 | -$5,000.00 | -$6,000.00 |
| 投资活动现金流净额 | $46.07M | $3.58M | -$71.23M | -$71.20M | -$50.76M |
| 持续经营投资活动现金流净额 | $46.07M | $3.58M | -$71.23M | -$71.20M | -$50.76M |
| 投资购置及出售净额 | $46.07M | $3.58M | -$71.23M | -$71.20M | -$50.76M |
| 筹资活动现金流 | $86.09M | $54.87M | $203.06M | $34.73M | $86.47M |
| 持续经营筹资活动现金流净额 | $86.09M | $54.87M | $203.06M | $34.73M | $86.47M |
| 普通股发行净额 | $85.24M | $54.72M | $202.63M | $34.66M | $86.12M |
| 股票期权行使所得 | $853,000.00 | $149,000.00 | $502,000.00 | $84,000.00 | $49,000.00 |
| 期末现金余额 | $154.68M | $62.10M | $45.54M | $45.54M | $112.67M |
| 现金净变动 | $92.58M | $16.56M | -$28.75M | -$67.13M | -$93,000.00 |
| 期初现金余额 | $62.10M | $45.54M | $74.29M | $112.67M | $112.77M |
| 自由现金流 | -$39.58M | -$41.89M | -$160.59M | -$30.66M | -$35.80M |
| 其他筹资费用净额 | – | – | -$70,000.00 | -$17,000.00 | $300,000.00 |
暂无评论——快来第一个聊聊 AVBP。
登录后参与讨论。